Adam R. Craig - 30 Jun 2021 Form 4 Insider Report for CTI BIOPHARMA CORP

Role
President and CEO, Director
Signature
Adam R. Craig
Issuer symbol
N/A
Transactions as of
30 Jun 2021
Net transactions value
+$15,962
Form type
4
Filing time
02 Dec 2021, 16:16:07 UTC
Next filing
11 Mar 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CTIC common stock Award $10,625 +5,000 +100% $2.12* 10,000 30 Jun 2021 Direct F1
transaction CTIC common stock Purchase $2,016 +1,322 +13% $1.52* 11,322 02 Dec 2021 Direct
transaction CTIC common stock Purchase $3,321 +2,178 +19% $1.52* 13,500 02 Dec 2021 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares acquired under the CTI BioPharma Corp. 2007 Employee Stock Purchase Plan.